[ Price : $8.95]
Xbrane Biopharma says it plans to resubmit a BLA before June for ranibizumab, a biosimilar copy of Genentechs Lucentis, which is i...[ Price : $8.95]
Eli Lilly wins FDA approval for Foundayo (orforglipron), a once-daily oral treatment for adults with obesity or those who are over...[ Price : $8.95]
Former FDA commissioner Robert Califf says form FDA-483 is a useful regulatory tool for identifying issues that companies should c...[ Price : $8.95]
FDA warns Henan, China-based Henan Lvyuan Pharmaceutical Company about significant deviations from current good manufacturing prac...[ Price : $8.95]
A Washington Legal Foundation background document suggests that Congress change direct-to-consumer disclaimer rules to recognize t...[ Price : $8.95]
Researchers at the University of Cincinnati begin a new study to investigate whether widely used diabetes and weight-loss drugs co...[ Price : $8.95]
FDA denies a 2024 Aimed Alliance petition asking for a guidance on human drug importation by alternative funding programs.[ Price : $8.95]
Agios Pharmaceuticals says it plans to seek accelerated approval for mitapivat in sickle cell disease, following a pre-submission ...